JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 3
Type: Invited
Date/Time: Sunday, July 29, 2012 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract - #303653
Title: How Much Missing Data Are Too Much in Clinical Trials of Neuropharmacological Drug Products
Author(s): Ohidul I Siddiqui*+
Companies: FDA
Address: 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA
Keywords: Repeated Measure Analysis ; , Longitudinal data analysis ; , missing data mechanism ; ignorable missing data

Missing data due to dropout of patients in randomized clinical trials are potential sources of bias in the efficacy evaluation of investigational drugs. The biases might be severe when the presence of missing data is substantial. Over the last two decades, extensive research works on dealing with missing data in clinical trials were conducted by both the academicians and pharmaceutical industry statisticians. Majority of the research findings supported the use of longitudinal data analysis for efficacy evaluation of study drugs instead of using the conventional last observation carried forward (LOCF) approach for dealing with missing at random (MAR) data in drug development research. However, there is a little evidence of exploring the impact of increases in the prevalence of missing data on biases in the statistical inferences. An attempt has been made in this research to explore such impacts based on an extensive simulation study and real clinical trial study data sets.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.